Krognes Steve E. has filed 80 insider transactions across 3 companies since December 2023.
Most recent transaction: a option exercise of 155 shares of Guardant Health, Inc. ($GH) on March 31, 2026.
Activity breakdown: 0 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 155 | $0.00 | 463.0000 | 131,170,441 | 25.08% | 0.00% |
| March 31, 2026 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 155 | $0.00 | 19,208.0000 | 131,170,441 | 0.81% | 0.00% |
| Feb. 28, 2026 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 618.0000 | 131,170,441 | 19.95% | 0.00% |
| Feb. 28, 2026 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 19,053.0000 | 131,170,441 | 0.81% | 0.00% |
| Jan. 31, 2026 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 18,899.0000 | 126,041,089 | 0.82% | 0.00% |
| Jan. 31, 2026 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 772.0000 | 126,041,089 | 16.63% | 0.00% |
| Dec. 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 18,745.0000 | 126,041,089 | 0.83% | 0.00% |
| Dec. 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 926.0000 | 126,041,089 | 14.26% | 0.00% |
| Nov. 30, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 155 | $0.00 | 1,080.0000 | 126,041,089 | 12.55% | 0.00% |
| Nov. 30, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 155 | $0.00 | 18,591.0000 | 126,041,089 | 0.84% | 0.00% |
| Oct. 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 18,436.0000 | 126,041,089 | 0.84% | 0.00% |
| Oct. 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 1,235.0000 | 126,041,089 | 11.09% | 0.00% |
| Sept. 30, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 1,389.0000 | 123,421,441 | 9.98% | 0.00% |
| Sept. 30, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 18,282.0000 | 123,421,441 | 0.85% | 0.00% |
| Aug. 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 155 | $0.00 | 18,128.0000 | 123,421,441 | 0.86% | 0.00% |
| Aug. 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 155 | $0.00 | 1,543.0000 | 123,421,441 | 9.13% | 0.00% |
| July 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 17,973.0000 | 123,421,441 | 0.86% | 0.00% |
| July 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 1,698.0000 | 123,421,441 | 8.32% | 0.00% |
| June 30, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 1,852.0000 | 123,421,441 | 7.68% | 0.00% |
| June 30, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 17,819.0000 | 123,421,441 | 0.87% | 0.00% |
| June 18, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | A | Stock Option (Right to Buy) | 6833 | $0.00 | 6,833.0000 | 123,421,441 | 9999.99% | 0.01% |
| June 18, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | A | Restricted Stock Units | 4203 | $0.00 | 4,203.0000 | 123,421,441 | 9999.99% | 0.00% |
| June 12, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 6674 | $0.00 | 17,665.0000 | 123,421,441 | 60.72% | 0.01% |
| June 12, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 6674 | $0.00 | 0.0000 | 123,421,441 | 100.00% | 0.01% |
| June 5, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Krognes Steve E. | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | A | Stock Option (right to buy) | 18111 | $0.00 | 18,111.0000 | 164,473,772 | 9999.99% | 0.01% |
| June 3, 2025 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | A | Common Stock | 6037 | $0.00 | 813,591.0000 | 164,473,772 | 0.75% | 0.00% |
| May 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 10,991.0000 | 123,421,441 | 1.42% | 0.00% |
| May 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 2,006.0000 | 123,421,441 | 7.13% | 0.00% |
| April 30, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 155 | $0.00 | 10,837.0000 | 123,421,441 | 1.45% | 0.00% |
| April 30, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 155 | $0.00 | 2,160.0000 | 123,421,441 | 6.70% | 0.00% |
| March 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 10,682.0000 | 123,421,441 | 1.46% | 0.00% |
| March 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 2,315.0000 | 123,421,441 | 6.24% | 0.00% |
| Feb. 28, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 10,528.0000 | 123,421,441 | 1.48% | 0.00% |
| Feb. 28, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 2,469.0000 | 123,421,441 | 5.87% | 0.00% |
| Jan. 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 10,374.0000 | 0 | 1.51% | 0.00% |
| Jan. 31, 2025 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 2,623.0000 | 0 | 5.55% | 0.00% |
| Jan. 7, 2025 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 3339 | $20.81 | 807,554.0000 | 164,473,772 | 0.41% | 0.00% |
| Dec. 31, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 30000 | $20.25 | 810,893.0000 | 169,456,988 | 3.57% | 0.02% |
| Dec. 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 155 | $0.00 | 2,777.0000 | 0 | 5.29% | 0.00% |
| Dec. 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 155 | $0.00 | 10,220.0000 | 0 | 1.54% | 0.00% |
| Nov. 30, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 2,932.0000 | 0 | 4.99% | 0.00% |
| Nov. 30, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 10,065.0000 | 0 | 1.55% | 0.00% |
| Oct. 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 3,086.0000 | 0 | 4.75% | 0.00% |
| Oct. 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 9,911.0000 | 0 | 1.58% | 0.00% |
| Sept. 30, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 30000 | $29.03 | 840,893.0000 | 137,370,897 | 3.44% | 0.02% |
| Sept. 30, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 9,757.0000 | 0 | 1.60% | 0.00% |
| Sept. 30, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 3,240.0000 | 0 | 4.54% | 0.00% |
| Aug. 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 155 | $0.00 | 9,603.0000 | 0 | 1.64% | 0.00% |
| Aug. 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 155 | $0.00 | 3,394.0000 | 0 | 4.37% | 0.00% |
| Aug. 20, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 1727 | $23.79 | 870,893.0000 | 137,370,897 | 0.20% | 0.00% |
| July 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 3,549.0000 | 0 | 4.16% | 0.00% |
| July 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 9,448.0000 | 0 | 1.66% | 0.00% |
| July 1, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 29900 | $22.12 | 872,720.0000 | 137,370,897 | 3.31% | 0.02% |
| June 13, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 688 | $21.79 | 890,836.0000 | 137,370,897 | 0.08% | 0.00% |
| July 1, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 100 | $22.80 | 872,620.0000 | 137,370,897 | 0.01% | 0.00% |
| June 30, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 3,703.0000 | 0 | 3.99% | 0.00% |
| June 30, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 9,294.0000 | 0 | 1.68% | 0.00% |
| June 13, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Krognes Steve E. | Director | A | Common Stock (Right to Buy) | 53528 | $0.00 | 53,528.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | A | Stock Option (Right to Buy) | 10703 | $0.00 | 10,703.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | A | Restricted Stock Units | 6674 | $0.00 | 6,674.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 5592 | $0.00 | 9,140.0000 | 0 | 157.61% | 0.00% |
| June 12, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 5592 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 31, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | A | Common Stock | 5967 | $0.00 | 903,308.0000 | 137,370,897 | 0.66% | 0.00% |
| May 31, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | A | Stock Option (right to buy) | 17901 | $0.00 | 17,901.0000 | 137,370,897 | 9999.99% | 0.01% |
| May 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 155 | $0.00 | 3,548.0000 | 0 | 4.57% | 0.00% |
| May 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 155 | $0.00 | 3,857.0000 | 0 | 3.86% | 0.00% |
| April 30, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 4,012.0000 | 0 | 3.70% | 0.00% |
| April 30, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 3,393.0000 | 0 | 4.75% | 0.00% |
| April 1, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 92500 | $20.50 | 897,341.0000 | 137,370,897 | 9.34% | 0.07% |
| March 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 4,166.0000 | 0 | 3.56% | 0.00% |
| March 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 3,239.0000 | 0 | 4.99% | 0.00% |
| Feb. 29, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 154 | $0.00 | 3,085.0000 | 0 | 5.25% | 0.00% |
| Feb. 29, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 154 | $0.00 | 4,320.0000 | 0 | 3.44% | 0.00% |
| Feb. 13, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 2750 | $17.29 | 989,841.0000 | 137,370,897 | 0.28% | 0.00% |
| Jan. 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Restricted Stock Units | 155 | $0.00 | 4,474.0000 | 0 | 3.35% | 0.00% |
| Jan. 31, 2024 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | Common Stock | 155 | $0.00 | 2,931.0000 | 0 | 5.58% | 0.00% |
| Jan. 5, 2024 | Denali Therapeutics Inc. | $DNLI | Krognes Steve E. | Director | S | Common Stock | 3208 | $19.43 | 992,591.0000 | 137,370,897 | 0.32% | 0.00% |
| Dec. 31, 2023 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | RESTRICTED STOCK UNITS | 154 | $0.00 | 4,629.0000 | 0 | 3.22% | 0.00% |
| Dec. 31, 2023 | Guardant Health, Inc. | $GH | Krognes Steve E. | Director | M | COMMON STOCK | 154 | $0.00 | 2,776.0000 | 0 | 5.87% | 0.00% |